West Pharmaceutical Services | WST - Current Assets



West Pharmaceutical Services reported $1.68B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Align Technology USD 2.45B 46.03M Jun/2025
Avanos Medical USD 356M 3.6M Jun/2025
Baxter International USD 7.04B 1.82B Mar/2025
Becton, Dickinson and Co. USD 9B 331M Jun/2025
Charles River Laboratories USD 1.47B 36.5M Jun/2025
Cooper Companies USD 2.14B 12.1M Jul/2025
Dentsply International USD 1.97B 12M Jun/2025
Haemonetics USD 913.16M 21.82M Jun/2025
ICU Medical USD 1.18B 243.8M Jun/2025
Insulet USD 2.28B 48.7M Jun/2025
Integra LifeSciences USD 1.14B 35.58M Jun/2025
IQVIA Holdings USD 6.35B 434M Jun/2025
J&J USD 71.55B 15.66B Mar/2025
Medtronic USD 23.81B 1.3B Apr/2025
Merit Medical Systems USD 923.07M 35.56M Jun/2025
Neogen USD 576.94M 25.22M May/2025
Quidel USD 1.28B 23.3M Jun/2025
Repligen USD 1.03B 33.58M Mar/2025
Solventum Corp 3.21B 155M Jun/2025
STAAR Surgical USD 292.79M 33.71M Jun/2025
Terumo JPY 718.08B 5.42B Jun/2025
West Pharmaceutical Services USD 1.68B 223.4M Jun/2025